Research interest include immunotherapy of cancer. A clinical vaccination program was established in which tumor-associated antigens loaded on DCs are used to treat both melanoma and colon cancer patients. A major current project is to translate the DC vaccination into pediatric oncological clinical setting. A primary scientific interest continues along the line of DC-immunotherapy and in particular the migration and imaging of DC.
Jolanda de Vries is Professor at the Department of Tumor Immunology.
<< go back